Growth Inhibition of Triple-Negative Breast Cancer: The Role of Spatiotemporal Delivery of Neoadjuvant Doxorubicin and Cisplatin

Growth Inhibition of Triple-Negative Breast Cancer: The Role of Spatiotemporal Delivery of Neoadjuvant Doxorubicin and Cisplatin

Combinations of platinum-based compounds with doxorubicin in free and/or in liposomal form for improved safety are currently being evaluated in the neoadjuvant setting on patients with advanced triple-negative breast cancer (TNBC). However, TNBC may likely be driven by chemotherapy-resistant cells....

Full description

Bibliographic Details
Main Authors: Dominick Salerno, Stavroula Sofou
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Pharmaceuticals
Subjects:
doxorubicin
cisplatin
combination chemotherapy
tumor spatiotemporal delivery
triple-negative breast cancer
liposomes
Online Access:https://www.mdpi.com/1424-8247/14/10/1035

Internet

https://www.mdpi.com/1424-8247/14/10/1035

Similar Items